Survey on patient preferences for myeloma treatment - Myeloma

Por um escritor misterioso

Descrição

  Dutch (Nederlands)  Voorkeuren van patiënten omtrent behandelingen voor myeloom Finnish (suomi) Potilaan mieltymykset myelooman hoidoista French (français) Préférences des patients concernant les traitements du myélome German (Deutsch) Patientenpräferenzen zu Myelombehandlungen Romanian (Română) Preferințele pacientului cu privire la tratamentele pentru mielom Spanish (Español) Preferencias del paciente sobre los tratamientos del mieloma     Our work is driven by the needs of myeloma patients. To best represent the patient voice in policy decisions, we need to…
Survey on patient preferences for myeloma treatment - Myeloma
How Multiple Myeloma Is Treated
Survey on patient preferences for myeloma treatment - Myeloma
PDF) Decision Aids: Assisting Patients With Multiple Myeloma and Caregivers With Treatment Decision Making
Survey on patient preferences for myeloma treatment - Myeloma
Multiple Myeloma Treatments
Survey on patient preferences for myeloma treatment - Myeloma
PDF) Patient Perceptions Regarding Multiple Myeloma and Its Treatment: Qualitative Evidence from Interviews with Patients in the United Kingdom, France, and Germany
Survey on patient preferences for myeloma treatment - Myeloma
Multiple Myeloma KYPROLIS® (carfilzomib)
Survey on patient preferences for myeloma treatment - Myeloma
Multiple Myeloma Cancer Support Community
Survey on patient preferences for myeloma treatment - Myeloma
Multiple Myeloma Treatments
Survey on patient preferences for myeloma treatment - Myeloma
Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment - Amaador - 2023 - Cancer Medicine - Wiley Online Library
Survey on patient preferences for myeloma treatment - Myeloma
Moving Toward a Cure for Myeloma American Society of Clinical Oncology Educational Book
Survey on patient preferences for myeloma treatment - Myeloma
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study - The Lancet Oncology
de por adulto (o preço varia de acordo com o tamanho do grupo)